SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-007053
Filing Date
2018-05-15
Accepted
2018-05-15 16:06:33
Documents
63
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 709057
2 ex31-1.htm EX-31.1 18243
3 ex31-2.htm EX-31.2 17942
4 ex32-1.htm EX-32.1 7739
5 ex32-2.htm EX-32.2 7535
  Complete submission text file 0001493152-18-007053.txt   3579298

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE heb-20180331.xml EX-101.INS 561376
7 XBRL SCHEMA FILE heb-20180331.xsd EX-101.SCH 53654
8 XBRL CALCULATION FILE heb-20180331_cal.xml EX-101.CAL 56373
9 XBRL DEFINITION FILE heb-20180331_def.xml EX-101.DEF 146087
10 XBRL LABEL FILE heb-20180331_lab.xml EX-101.LAB 348211
11 XBRL PRESENTATION FILE heb-20180331_pre.xml EX-101.PRE 230605
Mailing Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801
Business Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801 407-271-8516
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 18836411
SIC: 2836 Biological Products, (No Diagnostic Substances)